Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 78
Filtrar
1.
BMC Infect Dis ; 21(1): 537, 2021 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-34098877

RESUMO

BACKGROUND: Invasive aspergillosis of the central nervous system is a rare but increasingly prevalent disease. We present the unusual case of an immunosuppressed patient suffering from unexpected superinfected invasive aspergillosis with cerebral, pulmonal, and adrenal manifestations, mimicking a metastasized bronchial carcinoma. This report reveals the importance of including aspergillosis in the differential diagnosis of a cerebral mass lesion in the light of unspecific clinical findings. CASE PRESENTATION: A 58-year-old immunocompromised female presented to our emergency department with a single tonic-clonic seizure. Imaging showed a ring enhancing cerebral mass with perifocal edema and evidence of two smaller additional hemorrhagic cerebral lesions. In the setting of a mass lesion in the lung, and additional nodular lesions in the left adrenal gland the diagnosis of a metastasized bronchus carcinoma was suspected and the cerebral mass resected. However, histology did not reveal any evidence for a neoplastic lesion but septate hyphae consistent with aspergillus instead and microbiological cultures confirmed concomitant staphylococcal infection. CONCLUSIONS: A high index of suspicion for aspergillus infection should be maintained in the setting of immunosuppression. Clinical and radiological findings are often unspecific and even misleading. Definite confirmation usually relies on tissue diagnosis with histochemical stains. Surgical resection is crucial for establishing the diagnosis and guiding therapy with targeted antifungal medications.


Assuntos
Aspergilose/diagnóstico , Neoplasias Encefálicas/diagnóstico , Infecções Fúngicas do Sistema Nervoso Central/diagnóstico , Superinfecção/diagnóstico , Antifúngicos/uso terapêutico , Aspergilose/tratamento farmacológico , Aspergilose/imunologia , Aspergilose/patologia , Aspergillus/isolamento & purificação , Neoplasias Encefálicas/tratamento farmacológico , Neoplasias Encefálicas/patologia , Infecções Fúngicas do Sistema Nervoso Central/tratamento farmacológico , Infecções Fúngicas do Sistema Nervoso Central/imunologia , Infecções Fúngicas do Sistema Nervoso Central/patologia , Diagnóstico Diferencial , Feminino , Humanos , Hospedeiro Imunocomprometido , Pessoa de Meia-Idade , Staphylococcus/isolamento & purificação , Superinfecção/tratamento farmacológico , Superinfecção/imunologia , Superinfecção/patologia
2.
Intern Med ; 60(11): 1717-1722, 2021 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-33431734

RESUMO

A 47-year-old Japanese man was referred to our hospital because of a sustained high fever with diarrhea 12 days after a flight from India. Liver enzymes were elevated with rose spots, hepatosplenomegaly, relative bradycardia, and acute cholecystitis. A liver biopsy depicted the dense infiltration of lymphocytes and Kupffer cells in sinusoids and the granulomatous formation in the parenchyma. The liver damage was initially resolved with the administration of ceftriaxone for 16 days but flared up 1 week later. Laboratory tests yielded positive reactions for Salmonella typhi and hepatitis E virus RNA. The pathophysiological presentations of concurrent typhoid and type E hepatitis are discussed.


Assuntos
Vírus da Hepatite E , Hepatite , Superinfecção , Antibacterianos/uso terapêutico , Hepatite/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Salmonella typhi , Superinfecção/tratamento farmacológico
3.
Clin J Gastroenterol ; 14(2): 478-483, 2021 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-33393060

RESUMO

A 53-year-old woman visited a doctor and complained of chest discomfort after meals. Esophagogastroduodenoscopy showed multiple granular elevations in the gastric body. After biopsies from the elevations, she was diagnosed with mucosa-associated lymphoid tissue (MALT) lymphoma. Polymerase chain reaction also detected Helicobacter pylori and H. suis. Treatment to eradicate H. pylori and H. suis was successful. Endoscopic examination after the bacterial eradication treatment showed that multiple granular elevations remained in the gastric body; however, no lymphoma cells were found during histopathological examination. Thus, we reported a case of H. pylori-positive gastric MALT lymphoma with a unique morphology associated with H. suis superinfection.


Assuntos
Infecções por Helicobacter , Helicobacter heilmannii , Helicobacter pylori , Linfoma de Zona Marginal Tipo Células B , Neoplasias Gástricas , Superinfecção , Antibacterianos/uso terapêutico , Feminino , Infecções por Helicobacter/complicações , Infecções por Helicobacter/tratamento farmacológico , Humanos , Linfoma de Zona Marginal Tipo Células B/tratamento farmacológico , Pessoa de Meia-Idade , Neoplasias Gástricas/tratamento farmacológico , Superinfecção/tratamento farmacológico
4.
Ann Ital Chir ; 92020 Jul 24.
Artigo em Inglês | MEDLINE | ID: mdl-32876052

RESUMO

INTRODUCTION: Fungus ball (FB) represents a granulomatous mass due to a fungal colonization which may disseminate and potentially lead to a systemic infection. Maxillary fungus ball is considered to be a complication of dental treatment and, according to relevant literature, it often stems from improper endodontic therapies. MATERIAL AND METHODS: The authors report the case of a 69-year-old caucasian woman with nasal respiratory distress and frequent sinusitis symptoms. According to clinical and radiological evidence, FESS surgery was planned, thus validating FB diagnostic hypothesis. CONCLUSIONS: Fungal infection should always be considered in patients with sinusitis and previous root canal theraphy. Misdiagnosis can lead to severe complications. Surgical removal seems to be effective and resolutive. KEY WORDS: Endoscopic surgery, Fungus Ball, Maxillary sinusitiss.


Assuntos
Aspergillus flavus/isolamento & purificação , Complicações do Diabetes , Seio Maxilar , Sinusite , Idoso , Aspergilose/complicações , Aspergilose/diagnóstico por imagem , Aspergilose/cirurgia , Endoscopia , Feminino , Humanos , Seio Maxilar/diagnóstico por imagem , Seio Maxilar/microbiologia , Seio Maxilar/cirurgia , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Sinusite/diagnóstico por imagem , Sinusite/microbiologia , Sinusite/cirurgia , Infecções Estafilocócicas/tratamento farmacológico , Infecções Estafilocócicas/microbiologia , Superinfecção/tratamento farmacológico , Superinfecção/microbiologia
5.
Br J Haematol ; 191(3): 386-389, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-32762043

RESUMO

The COVID-19 pandemic has dramatically challenged care for cancer patients, especially those with active treatment who represent a vulnerable population for SARS-CoV-2 infection. Aggressive lymphoid neoplasms, such as diffuse large B cell lymphoma and high-grade B cell lymphoma, need to be treated without delay in order to get the best disease outcome. Because of that, our clinical practice was changed to minimise the risk of SARS-CoV-2 infection while continuing haematological treatment. In this report, we analyse the management of front-line therapy in 18 patients during the COVID-19 outbreak, as well as the results of the implemented measures in their outcome.


Assuntos
COVID-19/epidemiologia , Linfoma Difuso de Grandes Células B/tratamento farmacológico , Pandemias , Linfoma Plasmablástico/tratamento farmacológico , SARS-CoV-2 , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Antivirais/uso terapêutico , Azitromicina/uso terapêutico , Infecções Bacterianas/complicações , Infecções Bacterianas/tratamento farmacológico , COVID-19/complicações , COVID-19/prevenção & controle , Teste para COVID-19 , Ciclofosfamida/administração & dosagem , Ciclofosfamida/efeitos adversos , Doxorrubicina/administração & dosagem , Doxorrubicina/efeitos adversos , Neutropenia Febril/induzido quimicamente , Neutropenia Febril/prevenção & controle , Feminino , Fator Estimulador de Colônias de Granulócitos/uso terapêutico , Humanos , Hidroxicloroquina/uso terapêutico , Controle de Infecções/métodos , Masculino , Pessoa de Meia-Idade , Prednisona/administração & dosagem , Prednisona/efeitos adversos , Rituximab/administração & dosagem , Espanha/epidemiologia , Superinfecção/tratamento farmacológico , Vincristina/administração & dosagem , Vincristina/efeitos adversos , Tratamento Farmacológico da COVID-19
6.
CEN Case Rep ; 9(4): 370-374, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-32440858

RESUMO

We report a case of superinfection of liver cysts caused by Candida albicans and Staphylococcus lugdunensis in a patient with autosomal dominant polycystic kidney disease. A 69-year-old man with chief complaints of headache and blurred vision was admitted to the former institution for the evaluation of suspected temporal arteritis. He was prescribed oral prednisolone (55 mg/day) as a preemptive treatment; however, he became febrile and presented with bilateral flank pain during prednisolone tapering. Blood culture revealed fungemia as a result of Candida famata infection; thus, micafungin treatment was started. Thereafter, recrudescence of the C-reactive protein level ensued. Then a cyst infection as visualized on magnetic resonance imaging led to cyst aspiration sclerotherapy. Cyst aspirate culture revealed the presence of C. albicans in one of the cysts and S. lugdunensis in two of the cysts. The patient was clinically stabilized with an additional 3 weeks of antibiotic and antifungal drug administration.


Assuntos
Candida albicans/isolamento & purificação , Cistos/microbiologia , Rim Policístico Autossômico Dominante/tratamento farmacológico , Staphylococcus lugdunensis/isolamento & purificação , Superinfecção/tratamento farmacológico , Administração Oral , Idoso , Antibacterianos/uso terapêutico , Antifúngicos/uso terapêutico , Cistos/diagnóstico , Imagem de Difusão por Ressonância Magnética/métodos , Arterite de Células Gigantes/diagnóstico , Glucocorticoides/administração & dosagem , Glucocorticoides/uso terapêutico , Humanos , Fígado/patologia , Masculino , Rim Policístico Autossômico Dominante/complicações , Prednisolona/administração & dosagem , Prednisolona/uso terapêutico , Resultado do Tratamento
7.
J Investig Med High Impact Case Rep ; 8: 2324709620926900, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32462931

RESUMO

A 78-year-old male, originally from China, was brought to the hospital for weakness, urinary incontinence, confusion, and poor oral intake. He was started on empiric antibiotics, which were narrowed when blood cultures produced gram-negative bacteremia speciating to Klebsiella pneumoniae, sensitive to ceftriaxone. Computed tomography scan of the abdomen and pelvis demonstrated a large cystic region with air-fluid level in the left lobe of the liver. Suspecting this to be the source of the patient's bacteremia, the lesion was percutaneously drained and the fluid cultured, which also revealed ceftriaxone-sensitive Klebsiella pneumoniae. While a stool ova and parasite examination on the patient was negative, further workup was positive for Entamoeba histolytica antibody in the serum, detected via enzyme-linked immunosorbent assay and indicative of either current or past infection. This suggested possible prolonged subclinical infection with bacterial superinfection, especially given that Klebsiella pneumoniae is one of the most common organisms cultured from these abscesses. In patients with liver abscesses who immigrated from developing and/or endemic regions or have a relevant recent travel history, an underlying amoebic etiology of an abscess should be considered.


Assuntos
Entamoeba histolytica/isolamento & purificação , Infecções por Klebsiella/complicações , Klebsiella pneumoniae/isolamento & purificação , Abscesso Hepático Amebiano/complicações , Superinfecção/etiologia , Idoso , Antibacterianos/uso terapêutico , Anticorpos Antiprotozoários/sangue , Ceftriaxona/uso terapêutico , China , Ensaio de Imunoadsorção Enzimática , Humanos , Infecções por Klebsiella/diagnóstico , Infecções por Klebsiella/tratamento farmacológico , Abscesso Hepático Amebiano/diagnóstico , Abscesso Hepático Amebiano/tratamento farmacológico , Masculino , Superinfecção/tratamento farmacológico
8.
World J Gastroenterol ; 25(32): 4580-4597, 2019 Aug 28.
Artigo em Inglês | MEDLINE | ID: mdl-31528088

RESUMO

Chronic delta hepatitis is the most severe form of viral hepatitis affecting nearly 65 million people worldwide. Individuals with this devastating illness are at higher risk for developing cirrhosis and hepatocellular carcinoma. Delta virus is a defective RNA virus that requires hepatitis B surface antigen for propagation in humans. Infection can occur in the form of a co-infection with hepatitis B, which can be self-limiting, vs superinfection in a patient with established hepatitis B infection, which often leads to chronicity in majority of cases. Current noninvasive tools to assess for advanced liver disease have limited utility in delta hepatitis. Guidelines recommend treatment with pegylated interferon, but this is limited to patients with compensated disease and is efficacious in about 30% of those treated. Due to limited treatment options, novel agents are being investigated and include entry, assembly and export inhibitors of viral particles in addition to stimulators of the host immune response. Future clinical trials should take into consideration the interaction of hepatitis B and hepatitis D as suppression of one virus can lead to the activation of the other. Also, surrogate markers of treatment efficacy have been proposed.


Assuntos
Antivirais/uso terapêutico , Coinfecção/tratamento farmacológico , Hepatite B Crônica/tratamento farmacológico , Hepatite D Crônica/tratamento farmacológico , Superinfecção/tratamento farmacológico , Terapias em Estudo/métodos , Antivirais/farmacologia , Coinfecção/epidemiologia , Coinfecção/virologia , Quimioterapia Combinada/métodos , Carga Global da Doença , Antígenos de Superfície da Hepatite B/imunologia , Antígenos de Superfície da Hepatite B/metabolismo , Vírus da Hepatite B/imunologia , Vírus da Hepatite B/patogenicidade , Hepatite B Crônica/epidemiologia , Hepatite B Crônica/virologia , Hepatite D Crônica/epidemiologia , Hepatite D Crônica/virologia , Vírus Delta da Hepatite/imunologia , Vírus Delta da Hepatite/patogenicidade , Humanos , Interferon-alfa/farmacologia , Interferon-alfa/uso terapêutico , Lipopeptídeos/farmacologia , Lipopeptídeos/uso terapêutico , Transportadores de Ânions Orgânicos Dependentes de Sódio/antagonistas & inibidores , Transportadores de Ânions Orgânicos Dependentes de Sódio/metabolismo , Piperidinas/farmacologia , Piperidinas/uso terapêutico , Piridinas/farmacologia , Piridinas/uso terapêutico , Ensaios Clínicos Controlados Aleatórios como Assunto , Literatura de Revisão como Assunto , Superinfecção/epidemiologia , Superinfecção/virologia , Simportadores/antagonistas & inibidores , Simportadores/metabolismo , Resultado do Tratamento , Montagem de Vírus/efeitos dos fármacos , Internalização do Vírus/efeitos dos fármacos
10.
JCI Insight ; 4(14)2019 07 25.
Artigo em Inglês | MEDLINE | ID: mdl-31341107

RESUMO

Postinfluenza bacterial superinfections cause increased morbidity and mortality compared with singular infection with influenza during both pandemics and seasonal epidemics. Vaccines and current treatments provide limited benefit, a rationale to conduct studies utilizing alternative therapies. FY1 and an optimized version, MEDI8852, anti-influenza HA mAbs, have been shown to neutralize influenza virus during singular influenza infection. MEDI4893*, an anti-Staphylococcus aureus α-toxin mAb, has been shown to improve survival when administered prophylactically prior to S. aureus pneumonia. Our objective was to determine if mAbs can improve survival during postinfluenza bacterial pneumonia. We administered FY1 in a murine model of postinfluenza methicillin-resistant S. aureus (MRSA) pneumonia and observed improved survival rates when given early during the course of influenza infection. Our findings indicate decreased lung injury and increased uptake and binding of bacteria by macrophages in the mice that received FY1 earlier in the course of influenza infection, corresponding to decreased bacterial burden. We also observed improved survival when mice were treated with a combination of FY1 and MEDI4893* late during the course of postinfluenza MRSA pneumonia. In conclusion, both FY1 and MEDI4893* prolong survival when used in a murine model of postinfluenza MRSA pneumonia, suggesting pathogen-specific mAbs as a possible therapeutic in the context of bacterial superinfection.


Assuntos
Antibacterianos/uso terapêutico , Antivirais/uso terapêutico , Influenza Humana/tratamento farmacológico , Pneumonia Estafilocócica/tratamento farmacológico , Superinfecção/tratamento farmacológico , Animais , Antibacterianos/farmacologia , Anticorpos Monoclonais/farmacologia , Anticorpos Monoclonais/uso terapêutico , Anticorpos Monoclonais Humanizados/farmacologia , Anticorpos Monoclonais Humanizados/uso terapêutico , Antivirais/farmacologia , Anticorpos Amplamente Neutralizantes/farmacologia , Anticorpos Amplamente Neutralizantes/uso terapêutico , Modelos Animais de Doenças , Quimioterapia Combinada/métodos , Humanos , Vírus da Influenza A Subtipo H1N1/imunologia , Vírus da Influenza A Subtipo H1N1/patogenicidade , Influenza Humana/imunologia , Influenza Humana/mortalidade , Influenza Humana/virologia , Pulmão/imunologia , Pulmão/microbiologia , Pulmão/virologia , Macrófagos/efeitos dos fármacos , Macrófagos/imunologia , Masculino , Staphylococcus aureus Resistente à Meticilina/imunologia , Staphylococcus aureus Resistente à Meticilina/patogenicidade , Camundongos , Neutrófilos/efeitos dos fármacos , Neutrófilos/imunologia , Pneumonia Estafilocócica/imunologia , Pneumonia Estafilocócica/microbiologia , Pneumonia Estafilocócica/mortalidade , Superinfecção/imunologia , Superinfecção/microbiologia , Superinfecção/mortalidade , Análise de Sobrevida , Resultado do Tratamento
11.
BMJ Case Rep ; 12(3)2019 Mar 31.
Artigo em Inglês | MEDLINE | ID: mdl-30936324

RESUMO

Tubo-ovarian abscesses (TOAs) are inflammatory masses involving the fallopian tube, ovary and occasionally other adjacent pelvic organs. A 32-year-old woman with no significant medical history presented with a chief complaint of lower abdominal pain. Initial CT of the abdomen was suggestive of a colon abscess; however, a repeat CT suggested a TOA. The left ovary was densely adherent to the left pelvic sidewall and the rectosigmoid colon. The content of the ovary was consistent with a dermoid and suspected of superinfection. Pathological examination of the tissue revealed normal ovarian cortical tissue, hair cells, melanin, and epidermal and neural tissue, as well as evidence of a foreign object resembling vegetable matter. The vegetable fibre found in this patient's biopsy was of an unclear aetiology, but probably indicates a perforation of the bowel. Any cause of bowel perforation adjacent to the adnexa can lead to TOA, therefore providing a rational speculation for this case.


Assuntos
Dor Abdominal/etiologia , Abscesso/diagnóstico por imagem , Antibacterianos/uso terapêutico , Cisto Dermoide/patologia , Doenças das Tubas Uterinas/diagnóstico por imagem , Doenças Ovarianas/diagnóstico por imagem , Superinfecção/patologia , Dor Abdominal/diagnóstico por imagem , Dor Abdominal/patologia , Abscesso/patologia , Abscesso/terapia , Adulto , Ampicilina/uso terapêutico , Cisto Dermoide/diagnóstico por imagem , Cisto Dermoide/terapia , Doxiciclina/uso terapêutico , Doenças das Tubas Uterinas/patologia , Doenças das Tubas Uterinas/terapia , Feminino , Humanos , Perfuração Intestinal/patologia , Laparoscopia , Doenças Ovarianas/patologia , Doenças Ovarianas/terapia , Ovariectomia , Ovário/patologia , Sulbactam/uso terapêutico , Superinfecção/tratamento farmacológico , Tomografia Computadorizada por Raios X , Resultado do Tratamento
12.
Infect Immun ; 87(5)2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30804099

RESUMO

Influenza kills 30,000 to 40,000 people each year in the United States and causes 10 times as many hospitalizations. A common complication of influenza is bacterial superinfection, which exacerbates morbidity and mortality from the viral illness. Recently, methicillin-resistant Staphylococcus aureus (MRSA) has emerged as the dominant pathogen found in bacterial superinfection, with Streptococcus pneumoniae a close second. However, clinicians have few tools to treat bacterial superinfection. Current therapy for influenza/bacterial superinfection consists of treating the underlying influenza infection and adding various antibiotics, which are increasingly rendered ineffective by rising bacterial multidrug resistance. Several groups have recently proposed the use of the antiviral cytokine interferon lambda (IFN-λ) as a therapeutic for influenza, as administration of pegylated IFN-λ improves lung function and survival during influenza by reducing the overabundance of neutrophils in the lung. However, our data suggest that therapeutic IFN-λ impairs bacterial clearance during influenza superinfection. Specifically, mice treated with an adenoviral vector to overexpress IFN-λ during influenza infection exhibited increased bacterial burdens upon superinfection with either MRSA or S. pneumoniae Surprisingly, adhesion molecule expression, antimicrobial peptide production, and reactive oxygen species activity were not altered by IFN-λ treatment. However, neutrophil uptake of MRSA and S. pneumoniae was significantly reduced upon IFN-λ treatment during influenza superinfection in vivo Together, these data support the theory that IFN-λ decreases neutrophil motility and function in the influenza-infected lung, which increases the bacterial burden during superinfection. Thus, we believe that caution should be exercised in the possible future use of IFN-λ as therapy for influenza.


Assuntos
Antivirais/uso terapêutico , Influenza Humana/complicações , Influenza Humana/tratamento farmacológico , Interferons/uso terapêutico , Staphylococcus aureus/efeitos dos fármacos , Streptococcus pneumoniae/efeitos dos fármacos , Superinfecção/tratamento farmacológico , Animais , Modelos Animais de Doenças , Suscetibilidade a Doenças , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Infecções Estafilocócicas/patologia , Superinfecção/etiologia , Estados Unidos
14.
Eur J Pharmacol ; 833: 379-391, 2018 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-29935174

RESUMO

An estimated 240 million people worldwide are chronically infected with the hepatitis B virus (HBV). Despite readily available vaccination, HBV infections remain highly prevalent. As established HBV infections constitute a strong risk factor for developing hepatocellular carcinoma their treatment is a major task for the health system. Unfortunately, HBV is not curable with today's medicine. Approximately 15 million HBV patients have developed a hepatitis delta (HDV) infection on top of their HBV infection. The patients superinfected with this satellite virus suffer from a more severe disease development. The knowledge of the viruses, their classifications, clinical implications, treatment options and efforts to increase the drug variety are compiled in this review. The current standard therapies include nucleosidic reverse transcriptase inhibitors and interferon. As the known treatments fail to cure HBV and HDV, targeted treatment is highly warranted. The focus of this review is set on the drugs currently under clinical investigation. Furthermore, strategies for the development of targeted treatment, and compounds with novel mode of action are described.


Assuntos
Antivirais/uso terapêutico , Hepatite B Crônica/tratamento farmacológico , Hepatite D/tratamento farmacológico , Superinfecção/tratamento farmacológico , Antivirais/farmacologia , Antivirais/normas , Carcinoma Hepatocelular/epidemiologia , Carcinoma Hepatocelular/prevenção & controle , Carcinoma Hepatocelular/virologia , Ensaios Clínicos como Assunto , Vírus da Hepatite B/efeitos dos fármacos , Hepatite B Crônica/epidemiologia , Hepatite B Crônica/transmissão , Hepatite B Crônica/virologia , Hepatite D/epidemiologia , Hepatite D/transmissão , Hepatite D/virologia , Vírus Delta da Hepatite/efeitos dos fármacos , Hepatócitos/virologia , Humanos , Neoplasias Hepáticas/epidemiologia , Neoplasias Hepáticas/prevenção & controle , Neoplasias Hepáticas/virologia , Guias de Prática Clínica como Assunto , Prevalência , Superinfecção/epidemiologia , Superinfecção/virologia , Resultado do Tratamento , Replicação Viral/efeitos dos fármacos
16.
J Infect Chemother ; 24(12): 987-989, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29895453

RESUMO

We describe an extremely rare case of mediastinitis superinfected by emerging Achromobacter xylosoxidans. After mitral and aortic valves replacement, the patient first developed a Staphylococcus aureus mediastinitis, and five days after starting adapted antibiotic therapy, superficial pus analysis revealed the presence of Achromobacter xylosoxidans. This superinfection was considered superficial and focus was made on Staphylococcus aureus mediastinitis. Three weeks later, no more Staphylococcus aureus was found in pus samples and the sepsis seemed under control. Unfortunately, blood cultures were again positive for Achromobacter xylosoxidans three weeks later and the patient died from septic shock.


Assuntos
Achromobacter denitrificans/isolamento & purificação , Infecções por Bactérias Gram-Negativas/microbiologia , Mediastinite/microbiologia , Infecções Oportunistas/microbiologia , Choque Séptico/microbiologia , Superinfecção/microbiologia , Achromobacter denitrificans/efeitos dos fármacos , Achromobacter denitrificans/genética , Idoso de 80 Anos ou mais , Antibacterianos/uso terapêutico , Valva Aórtica/cirurgia , Evolução Fatal , Infecções por Bactérias Gram-Negativas/sangue , Infecções por Bactérias Gram-Negativas/complicações , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Humanos , Masculino , Mediastinite/sangue , Mediastinite/diagnóstico , Mediastinite/tratamento farmacológico , Valva Mitral/cirurgia , Infecções Oportunistas/sangue , Infecções Oportunistas/complicações , Infecções Oportunistas/tratamento farmacológico , Choque Séptico/sangue , Choque Séptico/complicações , Choque Séptico/tratamento farmacológico , Infecções Estafilocócicas/sangue , Infecções Estafilocócicas/complicações , Infecções Estafilocócicas/tratamento farmacológico , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/isolamento & purificação , Superinfecção/sangue , Superinfecção/complicações , Superinfecção/tratamento farmacológico , Supuração/microbiologia
17.
Transplant Proc ; 50(3): 861-866, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29661454

RESUMO

Strongyloides stercoralis (SS) can cause hyperinfection and disseminated infection in immunosuppressed individuals, with risk of mortality. We report the case of a cadaveric kidney transplant recipient who developed gastrointestinal symptoms and eosinophilia, approximately 3 months after transplantation. Stool examination and esophagogastroduodenoscopy with biopsies were positive for SS larvae. The patient was started on oral ivermectin and immunosuppression was reduced, but still the clinical picture got worse with metabolic ileus and respiratory symptoms, with the need for administration of subcutaneous ivermectin and combined therapy with albendazol. The patient survived and graft function was preserved. The patient was unlikely to be the source of infection. We also present a review of cases of SS infection in kidney transplant recipients.


Assuntos
Eosinofilia/imunologia , Hospedeiro Imunocomprometido , Transplante de Rim/efeitos adversos , Complicações Pós-Operatórias/imunologia , Estrongiloidíase/imunologia , Superinfecção/imunologia , Albendazol/uso terapêutico , Animais , Antiparasitários/uso terapêutico , Biópsia , Quimioterapia Combinada , Eosinofilia/parasitologia , Humanos , Terapia de Imunossupressão/métodos , Ivermectina/uso terapêutico , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/tratamento farmacológico , Complicações Pós-Operatórias/parasitologia , Strongyloides stercoralis , Estrongiloidíase/tratamento farmacológico , Estrongiloidíase/parasitologia , Superinfecção/tratamento farmacológico , Superinfecção/parasitologia
20.
Actas Dermosifiliogr ; 108(6): e45-e48, 2017.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-28411862

RESUMO

Photodynamic therapy (PDT) is a therapeutic modality with significant antimicrobial activity. We present 2 cases of chronic lower limb ulcers in which fungal and bacterial superinfection complicated management. PDT with methylene blue as the photosensitizer led to clinical and microbiological cure with no significant adverse effects. PDT with methylene blue is a valid option for the management of superinfected chronic ulcers, reducing the use of antibiotics and the induction of resistance.


Assuntos
Fusariose/tratamento farmacológico , Fusarium/efeitos dos fármacos , Úlcera da Perna/microbiologia , Azul de Metileno/uso terapêutico , Micoses/tratamento farmacológico , Fotoquimioterapia , Fármacos Fotossensibilizantes/uso terapêutico , Infecções por Pseudomonas/tratamento farmacológico , Pseudomonas aeruginosa/efeitos dos fármacos , Superinfecção/tratamento farmacológico , Adulto , Idoso , Queimaduras por Corrente Elétrica/complicações , Queimaduras por Corrente Elétrica/microbiologia , Doença Crônica , Feminino , Fusariose/etiologia , Humanos , Hospedeiro Imunocomprometido , Complicações Intraoperatórias , Úlcera da Perna/complicações , Micoses/etiologia , Infecções por Pseudomonas/etiologia , Superinfecção/etiologia , Cicatrização , Infecção dos Ferimentos/tratamento farmacológico , Infecção dos Ferimentos/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA